These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16325471)

  • 1. Towards high-throughput functional target discovery in angiogenesis research.
    van Beijnum JR; Eijgelaar WJ; Griffioen AW
    Trends Mol Med; 2006 Jan; 12(1):44-52. PubMed ID: 16325471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense and RNA interference approaches to target validation in pain research.
    Kurreck J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):179-87. PubMed ID: 15603251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tools for target identification and validation.
    Wang S; Sim TB; Kim YS; Chang YT
    Curr Opin Chem Biol; 2004 Aug; 8(4):371-7. PubMed ID: 15288246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation.
    Chatterjee-Kishore M; Miller CP
    Drug Discov Today; 2005 Nov; 10(22):1559-65. PubMed ID: 16257379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and proteomics approaches in understanding tumor angiogenesis.
    Mittal V; Nolan DJ
    Expert Rev Mol Diagn; 2007 Mar; 7(2):133-47. PubMed ID: 17331062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methodology of analysis of molecular-genetic basis of the brain physiology--functional neurogenomics].
    Dygalo NN
    Usp Fiziol Nauk; 2007; 38(1):3-13. PubMed ID: 17370666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-based approaches in cancer therapy.
    Devi GR
    Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense and RNAi: powerful tools in drug target discovery and validation.
    Lavery KS; King TH
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setting sights on the treatment of ocular angiogenesis using antisense oligonucleotides.
    Henry SP; Marcusson EG; Vincent TM; Dean NM
    Trends Pharmacol Sci; 2004 Oct; 25(10):523-7. PubMed ID: 15380936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The zebrafish as a novel system for functional genomics and therapeutic development applications.
    Nasevicius A; Ekker SC
    Curr Opin Mol Ther; 2001 Jun; 3(3):224-8. PubMed ID: 11497344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis.
    Hadj-Slimane R; Lepelletier Y; Lopez N; Garbay C; Raynaud F
    Biochimie; 2007 Oct; 89(10):1234-44. PubMed ID: 17707573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput target discovery using cell-based genetics.
    Jackson PD; Harrington JJ
    Drug Discov Today; 2005 Jan; 10(1):53-60. PubMed ID: 15676299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developmental insights from high-throughput biological analysis in Caenorhabditis elegans.
    Labbé JC; Roy R
    Clin Genet; 2006 Apr; 69(4):306-14. PubMed ID: 16630163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi: a novel antisense technology and its therapeutic potential.
    Dallas A; Vlassov AV
    Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional genomics in hypertension.
    McBride MW; Graham D; Delles C; Dominiczak AF
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):145-51. PubMed ID: 16481881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemogenomics approaches to novel target discovery.
    Gaither LA
    Expert Rev Proteomics; 2007 Jun; 4(3):411-9. PubMed ID: 17552925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern genetic approaches to the search for targets for medicinal preparations].
    Sarantseva SV; Shvartsman AL
    Genetika; 2009 Jul; 45(7):869-80. PubMed ID: 19705737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.